Pharmacogenetics education: 10 years of experience at Tel Aviv University

Pharmacogenomics

Volumn 11, Issue 5, 2010, Pages 647-649

  Gurwitz, David ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Continued medical education; Education; Pharmacogenetics; Pharmacogenomics

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 2D6;

ADVERSE DRUG REACTION; AWARENESS; CONTINUING EDUCATION; CURRICULUM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEALTH CARE PERSONNEL; HUMAN; ISRAEL; MEDICAL EDUCATION; NOTE; PHARMACODYNAMICS; PHARMACOGENETICS; PHARMACOKINETICS; SINGLE NUCLEOTIDE POLYMORPHISM; TEACHING; UNIVERSITY;

CURRICULUM; FACULTY; HUMANS; ISRAEL; MEDICINE; PHARMACOGENETICS; TEACHING; UNIVERSITIES;

EID: 77951619727     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.30     Document Type: Note

References (20)

1. Need AC, Motulsky AG, Goldstein DB: Priorities and standards in pharmacogenetic research. Nat Genet. 37(7), 671-681 (2005).
2. Giacomini KM, Krauss RM, Roden DM et al.: When good drugs go bad. Nature 2446(7139), 975-977 (2007).
3. Gurwitz D, Motulsky AG: 'Drug reactions, enzymes, and biochemical genetics': 50 years later. Pharmacogenomics 8(11), 1479-1484 (2007).
4. Woodcock J, Lesko LJ: Pharmacogenetics-tailoring treatment for the outliers. N. Engl. J. Med. 360(8), 811-813 (2009).
5. Hopkins MM, Ibarreta D, Gaisser S et al.: Putting pharmacogenetics into practice. Nat. Biotechnol. 24(4), 403-410 (2006).
6. Gurwitz D, Zika E, Hopkins MM, Gaisser S, Ibarreta D: Pharmacogenetics in Europe: barriers and opportunities. Public Health Genomics 12(3), 134-141 (2009).
7. Payne K: Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key. Pharmacogenomics 9(1), 1-4 (2008).
8. Davis JC, Furstenthal L, Desai AA et al.: The microeconomics of personalized medicine: today's challenge and tomorrow's promise. Nat. Rev. Drug Discov. 8(4), 279-286 (2009).
9. Ikediobi ON, Shin J, Nussbaum RL et al.: Addressing the challenges of the clinical application of pharmacogenetic testing. Clin. Pharmacol. Ther. 86(1), 28-31 (2009).
10. Higgs J, Gambhir N, Ramsden SC, Poulton K, Newman WG: Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories. Genet. Test. Mol. Biomarkers 14(1), 121-125 (2009).
11. Gurwitz D, Weizman A, Rehavi M: Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends Pharmacol. Sci. 224(3), 122-125 (2003).
12. Frueh FW, Gurwitz D: From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community. Pharmacogenomics 5(5), 571-579 (2004).
13. Gurwitz D, Lunshof JE, Dedoussis G et al.: Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J. 5(4), 221-225 (2005).
14. Lunshof JE, Gurwitz D: Response to Sykiotis and Papavassiliou: professional education in molecular medicine-pharmacogenetics frst. Trends Mol. Med. 211(11), 485-486 (2005).
15. Hedgecoe A: Education, ethics and knowledge defcits in clinical pharmacogenetics. Pharmacogenomics 8(3), 267-270 (2007).
16. Burke S, Martyn M, Thomas H, Farndon P: The development of core learning outcomes relevant to clinical practice: identifying priority areas for genetics education for non-genetics specialist registrars. Clin. Med. 9(1), 49-52 (2009).
17. Pirmohamed M, James S, Meakin S et al.: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456), 15-19 (2004). (Pubitemid 38869995)
18. Budnitz DS, Pollock DA, Weidenbach KN et al.: National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296(15), 1858-1866 (2006).
19. Higgs JE, Andrews J, Gurwitz D, Payne K, Newman W: Pharmacogenetics education in British medical schools. Genomic Med. 2(3-4), 101-105 (2008).
20. Lunshof JE, Pirmohamed M, Gurwitz D: Personalized medicine: decades away? Pharmacogenomics 7(2), 237-241 (2006).